Residual effects of zolpidem, zopiclone and flunitrazepam on the processing of visual information in driving context

Revue europeenne de psychologie appliquee

Volumn 58, Issue 2, 2008, Pages 111-116

  Berthelon, C ^a   de Longcamp, A ^b   Coquerel, A ^b   Denise, P ^b  

^a Department of Accident Mechanism Analysis   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

Hypnotic; Residual effect; Road driving; Visual processing

Indexed keywords

EID: 44549088742     PISSN: 11629088     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.erap.2006.06.001     Document Type: Article

References (37)

1. Barbone F., Mac Mahon A., Davey P., Morris A., Reid I., Mac Devitt D., and Mac Donald T. Association of road-traffic accidents with benzodiazepine use. Lancet 352 (1998) 1331-1336
2. Berthelon C., Bocca M.-L., Denise P., and Pottier A. Do zopiclone, zolpidem and flunitrazepam have residual effects on simulated task of collision anticipation?. Journal of Psychopharmacology 17 (2003) 324-331
3. Berthelon C., Mestre D., and Taramino R. Anticipation visuelle de collisions en situations simulées: effets de l'expérience de la conduite. Le Travail Humain 58 (1995) 311-338
4. Bocca M.-L., Le Doze F., Etard O., Pottier M., L'Hoste J., and Denise P. Residual effects of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades. Psychopharmacology 143 (1999) 373-379
5. Brookhuis K.A., Volkerts E.R., and O'Hanlon J.F. Repeated dose effects of lormazepam and flurazepam upon driving performance. European Journal of Clinical Pharmacology 39 (1990) 83-87
6. Cavallo V., and Laurent M. Visual information and skill level in time to collision estimation. Perception 17 (1988) 623-632
7. Cavallo V., Mestre D., and Berthelon C. Time-to-collision judgments: visual and spatio-temporal factors. In: Rothengatter J.A., and Carbonell Vaya E.J. (Eds). Traffic and Transport Psychology: Theory and Application (1997), Elsevier Science Publisher B.V, Amsterdam 97-111
8. De Gier, J.J., 1999. Review of investigations of prevalence of illicit drugs in road traffic in different European countries. Proceedings of the Road and Traffic Drugs Seminar, organised by the co-operation group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group), 19 and 20 April 1999, Strasbourg, France. Publication of the European Council, pp. 13-63.
9. DeLucia P.R., Bleckey M.K., Meyer E., and Bush J.M. Judgments about collision in younger and older drivers. Transportation Research Part F: Traffic Psychology and Behaviour 6 (2003) 63-80
10. Giersch A., and Herzog M.H. Lorazepam strongly prolongs visual information processing. Neuropsychopharmacology 29 (2004) 1386-1394
11. Gray R., and Regan D. Do monocular time-to-collision estimates necessarily involve perceived distance?. Perception 28 (1999) 1257-1264
12. Groeger J.A. Trafficking in cognition: applying cognitive psychology to driving. Transportation Research Part F: Traffic Psychology and Behaviour 5 (2002) 235-248
13. Hancock P.A., and Manser M.P. Time-to-contact: more than Tau alone. Ecological Psychology 9 (1997) 265-297
14. Harrison C., Subhan Z., and Hindmarch I. Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related to car driving. Drugs Under Experimental and Clinical Research 11 (1985) 823-829
15. Hemmelgarn B., Suissa S., Huang A., Boivin J.-F., and Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278 (1997) 27-31
16. Kemeny A., and Panerai F. Evaluating perception in driving simulation experiments. Trends in Cognitive Sciences 7 (2003) 31-37
17. Klein B.E., Klein R., Knudtson M.D., Lee K.E., Danforth L.G., Reinke J.O., and Adler A.M. Associations of selected medications and visual function: the Beaver Dam Eye Study. British Journal of Ophthalmology 87 (2003) 403-408
18. Manser M.P., and Hancock P.A. Influence of approach angle on estimates of time-to-contact. Ecological Psychology 8 (1996) 71-99
19. Marquet P., Gautier J.-M., and Merle L. Les médicaments anxiolitiques, hypnotiques et antidépresseurs. In: Mura P. (Ed). Alcool, médicaments, stupéfiants et conduite automobile. Collection Option Bio (1999), Elsevier, France 21-58
20. Menzin J., Lang K.M., Levy P., and Levy E. A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France. Pharmacoeconomics 19 1 (2001) 69-78
21. Neutel C.I. Risk of traffic accident injury after a prescription for a benzodiazepine. Annals of Epidemiology 5 (1995) 239-244
22. O'Hanlon J.F. Zopiclone's residual effects on psychomotor and information processing skills involved in complex tasks such as car driving: a critical review. European Psychiatry 10 Suppl. 3 (1995) 137s-143s
23. O'Hanlon J.F., Vermeeren A., Uiterwijk M.M.C., van Veggel L.M.A., and Swijgman H.F. Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. Neuropsychobiology 31 (1995) 81-88
24. Ohayon M.M., and Lader M.H. Use do psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. The Journal of Clinical Psychiatry 63 (2002) 817-825
25. Recarte M.A., and Nunes L.M. Perception of speed in an automobile: estimation and production. Journal of Experimental Psychology. Applied 2 (1996) 291-304
26. Riedel W.J., Vermeeren A., van Boxtel M.P.J., Vuurman E.F.P.M., Verdhey F.R.J., Jolles J., and Ramaekers J.G. Mechanisms of drug-induced driving impairment: a dimensional approach. Human Psychopharmacology : Clinical Experimental 13 (1998) S49-S63
27. Sanger D.J. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 18 Suppl. 1 (2004) 9-15
28. Sherwood N. A critical review of drugs and driving. Behavioural Research in Road Safety VIII 11 (1998) 49-58
29. Staner L., Ertlé S., Boeijinga P., Rinaudo G., Arnal M.A., Muzet A., and Luthringer R. Next-day residual effects of hypnotics in DMS-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology 181 (2005) 790-798
30. Unden M., and Schechter B.R. Next day effects after nighttime treatment with zolpidem: a review. European Psychiatry 11 Suppl. 1 (1996) 21s-30s
31. Vermeeren A. Residual effects of hypnotics. Epidemiology and clinical implications. CNS Drugs 18 (2004) 297-328
32. Vermeeren A., Danjou P.E., and O'Hanlon J.F. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Human Psychopharmacology 13 (1998) S98-S107
33. Vermeeren A., O'Hanlon J.F., and Declerck A.C. Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Therapeutica 21 (1995) 47-64
34. Vermeeren A., Riedel W.J., Van Boxtel M.P.J., Darwish M., Paty I., and Patat A. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 25 (2002) 224-231
35. Verster J.C., Veldhuijzen D.S., and Volkerts E.R. Residual effects of sleep medication on driving ability. Sleep Medicine Reviews 8 (2004) 309-325
36. Verster J.C., Volkerts E.R., Schreuder A.H., Eijken E.J., van Heuckelum J.H., Veldhuijzen D.S., et al. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance. Journal of Clinical Psychopharmacology 22 (2002) 576-583
37. Volkerts, E.R., Louwerens, J.W., Gloerich, A.B.M., Brookhuis, K.J., O'Hanlon, J.F., 1984. Zopiclone's residual effect upon actual driving performance versus those of nitrazepam and flunitrazepam. Technical report VK-84-10. Traffic Research Center, University of Groningen, The Netherlands.